[{"Assets_0_Q1_USD":"38006800000.0","CIK":"59478","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"4.33","EarningsPerShareDiluted_1_Q1_USD":"4.31","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q1_USD":"84700000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"311300000.0","NetIncomeLoss_1_Q1_USD":"4241600000.0","OfficialName":"Eli Lilly and Company Common Stock","PaymentsOfDividends_1_Q1_USD":"637200000.0","RevenuesConverted_1_Q1_USD":"5092200000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"2565000000.0","StockholdersEquity_0_Q1_USD":"2480300000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"984000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"979900000.0","filed":"20190502","footnote":null,"form":"10-Q","fp":"Q1","fy":"2019.0","name":"LILLY ELI & CO","period":"20190331","qtrs":"0","uom":"USD"}]